Sorrento Therapeutics (SRNE) Short Interest Ratio & Short Volume $0.0008 0.00 (-33.33%) (As of 12/20/2024 05:32 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsInsider TradesOptions ChainSEC FilingsSustainabilityTrends Sorrento Therapeutics Short Interest DataSorrento Therapeutics (SRNE) has a short interest of 64.56 million shares. This marks a 3.33% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.8, indicating that it would take 5.8 days of the average trading volume of 278,378 shares to cover all short positions.Current Short Interest64,560,000 sharesPrevious Short Interest62,480,000 sharesChange Vs. Previous Month+3.33%Dollar Volume Sold Short$61.88 millionShort Interest Ratio5.8 Days to CoverLast Record DateJanuary 31, 2023Outstanding Shares551,281,000 sharesPercentage of Shares Shorted11.71%Today's Trading Volume282,107 sharesAverage Trading Volume278,378 sharesToday's Volume Vs. Average101% Short Selling Sorrento Therapeutics? Sign up to receive the latest short interest report for Sorrento Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSRNE Short Interest Over TimeSRNE Days to Cover Over TimeSRNE Percentage of Float Shorted Over Time Ad Stansberry ResearchThis Warning flashed just before the dot-com bust and the Great DepressionA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the market crashed 78% (the dot-com bust) and 89% (the Great Depression). Today, according to one of America's leading experts (who has predicted nearly every financial crisis of the last 25 years), what's coming next could soon crash the market by 50% or more, and keep it down for 10, 20, or even 30 years. Click here for all the details. Sorrento Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202364,560,000 shares $61.88 million +3.3%N/A5.8 $0.96 1/15/202362,480,000 shares $70.60 million +1.7%N/A6.1 $1.13 12/30/202261,440,000 shares $54.44 million +3.6%N/A6.3 $0.89 12/15/202259,330,000 shares $62.89 million -4.3%N/A7 $1.06 11/30/202261,990,000 shares $80.59 million +7.1%N/A8.5 $1.30 11/15/202257,910,000 shares $95.55 million -3.7%N/A8 $1.65 Get the Latest News and Ratings for SRNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sorrento Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/202260,120,000 shares $94.39 million -0.9%N/A7.9 $1.57 10/15/202260,670,000 shares $81.30 million +3.4%N/A7.7 $1.34 9/30/202258,680,000 shares $92.13 million +3.9%N/A6.9 $1.57 9/15/202256,500,000 shares $118.09 million +4.4%N/A6 $2.09 8/31/202254,110,000 shares $110.93 million -1.9%N/A5.1 $2.05 8/15/202255,130,000 shares $151.61 million -8.4%N/A5.3 $2.75 7/31/202260,200,000 shares $156.52 million +5.7%N/A5.8 $2.60 7/15/202256,970,000 shares $148.12 million -5.2%N/A5.3 $2.60 6/30/202260,070,000 shares $120.74 million +15.6%N/A5.7 $2.01 6/15/202251,960,000 shares $84.69 million -3.9%N/A5.2 $1.63 5/31/202254,080,000 shares $88.69 million +2.1%N/A5.7 $1.64 5/15/202252,970,000 shares $75.75 million -3.1%N/A5.6 $1.43 4/30/202254,660,000 shares $82.54 million +2.0%N/A6.1 $1.51 4/15/202253,580,000 shares $101.27 million +2.3%N/A5.9 $1.89 3/31/202252,390,000 shares $122.07 million +16.5%N/A6.2 $2.33 3/15/202244,990,000 shares $97.18 million -2.6%N/A5.5 $2.16 2/28/202246,210,000 shares $116.91 million +1.5%N/A6.5 $2.53 2/15/202245,520,000 shares $142.02 million -1.5%16.1%6.7 $3.12 1/31/202246,190,000 shares $159.36 million +10.7%16.3%7 $3.45 1/15/202241,720,000 shares $190.24 million -2.7%14.7%7.2 $4.56 12/31/202142,890,000 shares $199.44 million -2.9%15.2%8.1 $4.65 12/15/202144,150,000 shares $272.85 million -2.7%15.6%8.4 $6.18 11/30/202145,360,000 shares $270.35 million +0.1%16.0%9.2 $5.96 11/15/202145,320,000 shares $276.91 million -0.6%16.0%9.5 $6.11 10/29/202145,600,000 shares $312.82 million -0.9%16.3%9.7 $6.86 10/15/202146,030,000 shares $314.85 million +0.8%16.5%9.9 $6.84 9/30/202145,660,000 shares $348.39 million +6.0%16.4%9.4 $7.63 9/15/202143,070,000 shares $341.98 million -0.5%15.5%7.5 $7.94 8/31/202143,290,000 shares $389.61 million -7.2%15.7%6.9 $9.00 8/13/202146,640,000 shares $421.63 million -3.7%17.0%7.1 $9.04 7/30/202148,420,000 shares $397.53 million +0.2%17.6%7.2 $8.21 7/15/202148,330,000 shares $382.77 million -4.0%17.6%6.7 $7.92 6/30/202150,360,000 shares $487.99 million -0.9%18.4%6.6 $9.69 6/15/202150,830,000 shares $455.44 million +0.3%18.9%7 $8.96This Warning flashed just before the dot-com bust and the Great Depression (Ad)A rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the market crashed 78% (the dot-com bust) and 89% (the Great Depression). Today, according to one of America's leading experts (who has predicted nearly every financial crisis of the last 25 years), what's coming next could soon crash the market by 50% or more, and keep it down for 10, 20, or even 30 years. Click here for all the details. 5/28/202150,660,000 shares $380.96 million -5.2%18.8%7.1 $7.52 5/14/202153,420,000 shares $339.22 million -5.6%N/A6.4 $6.35 4/30/202156,610,000 shares $480.05 million -4.9%N/A5.4 $8.48 4/15/202159,550,000 shares $439.78 million +6.4%N/A4.1 $7.39 3/31/202155,980,000 shares $447.84 million -0.2%N/A3.4 $8.00 3/15/202156,070,000 shares $574.72 million -1.5%N/A3.2 $10.25 2/26/202156,940,000 shares $576.23 million -11.2%N/A3.1 $10.12 2/12/202164,150,000 shares $957.76 million +6.9%N/A3.4 $14.93 1/29/202160,020,000 shares $734.04 million -14.8%N/A3.1 $12.23 1/15/202170,470,000 shares $563.06 million -4.2%N/A4.2 $7.99 12/31/202073,590,000 shares $532.42 million +6.7%N/A5.1 $7.24 12/15/202068,980,000 shares $516.66 million +0.1%N/A4.1 $7.49 11/30/202068,910,000 shares $561.62 million -8.6%N/A3.3 $8.15 11/15/202075,390,000 shares $486.27 million +3.6%N/A3.4 $6.45 10/30/202072,750,000 shares $529.62 million +1.2%N/A2.6 $7.28 10/15/202071,880,000 shares $725.99 million -5.1%N/A1.8 $10.10 9/30/202075,730,000 shares $844.39 million +0.8%N/A1.8 $11.15 9/15/202075,110,000 shares $521.26 million +2.4%N/A1.7 $6.94 8/31/202073,350,000 shares $587.53 million +35.7%N/A1.8 $8.01 8/14/202054,060,000 shares $672.51 million +3.4%N/A1.3 $12.44 7/31/202052,300,000 shares $466.52 million +8.0%N/A1.1 $8.92 7/15/202048,410,000 shares $318.54 million -3.3%N/A1.3 $6.58 6/30/202050,080,000 shares $314.50 million +21.4%N/A1.5 $6.28 6/15/202041,260,000 shares $201.76 million +11.3%N/A1.4 $4.89 5/29/202037,060,000 shares $187.15 million +57.1%N/A1.4 $5.05 5/15/202023,590,000 shares $159.47 million -2.5%N/A1 $6.76 4/30/202024,200,000 shares $54.93 million -2.2%N/A3.6 $2.27 4/15/202024,750,000 shares $63.61 million +3.9%N/A3.8 $2.57 3/31/202023,830,000 shares $61.24 million -3.4%N/A3.4 $2.57 3/13/202024,668,300 shares $62.41 million +3.6%N/A3.2 $2.53 2/28/202023,810,000 shares $48.81 million -3.1%N/A4.2 $2.05 2/14/202024,580,000 shares $50.39 million -2.9%N/A3.4 $2.05 1/31/202025,320,000 shares $56.72 million +8.3%N/A3.7 $2.24 1/15/202023,370,000 shares $65.67 million -3.1%N/A3.8 $2.81 12/31/201924,120,000 shares $102.99 million +8.8%N/A4.1 $4.27 SRNE Short Interest - Frequently Asked Questions What is Sorrento Therapeutics' current short interest? Short interest is the volume of Sorrento Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 64,560,000 shares of SRNE short. Learn More on Sorrento Therapeutics' current short interest. What is a good short interest ratio for Sorrento Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SRNE shares currently have a short interest ratio of 6.0. Learn More on Sorrento Therapeutics's short interest ratio. Is Sorrento Therapeutics' short interest increasing or decreasing? Sorrento Therapeutics saw a increase in short interest in the month of January. As of January 31st, there was short interest totaling 64,560,000 shares, an increase of 3.3% from the previous total of 62,480,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sorrento Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sorrento Therapeutics: SciSparc Ltd. (0.93%), Dermata Therapeutics, Inc. (2.85%), Clearmind Medicine Inc. (6.38%), Cyclacel Pharmaceuticals, Inc. (3.11%), Aptevo Therapeutics Inc. (7.60%), Galmed Pharmaceuticals Ltd. (1.39%), Akanda Corp. (7.32%), Salarius Pharmaceuticals, Inc. (2.60%), 180 Life Sciences Corp. (13.23%), Virpax Pharmaceuticals, Inc. (5.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.19 billion), Snowflake Inc. ($2.35 billion), T. Rowe Price Group, Inc. ($2.14 billion), Coinbase Global, Inc. ($2.14 billion), Paramount Global ($1.99 billion), Etsy, Inc. ($1.76 billion), Lucid Group, Inc. ($1.70 billion), Wayfair Inc. ($1.63 billion), Old Dominion Freight Line, Inc. ($1.61 billion), and CarMax, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Sorrento Therapeutics stock? Short selling SRNE is an investing strategy that aims to generate trading profit from Sorrento Therapeutics as its price is falling. SRNE shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sorrento Therapeutics? A short squeeze for Sorrento Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SRNE, which in turn drives the price of the stock up even further. How often is Sorrento Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SRNE, twice per month. The most recent reporting period available is January, 31 2023. More Short Interest Resources from MarketBeat Related Companies SciSparc Short Interest Data Dermata Therapeutics Short Interest Data Clearmind Medicine Short Interest Data Cyclacel Pharmaceuticals Short Interest Data Aptevo Therapeutics Short Interest Data Galmed Pharmaceuticals Short Interest Data Akanda Short Interest Data Salarius Pharmaceuticals Short Interest Data 180 Life Sciences Short Interest Data Virpax Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SRNE) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sorrento Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sorrento Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRNE Stock Alerts